ArriVent BioPharma, Inc. Common Stock
AVBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,978 | -$31,399 | -$64,387 | -$20,633 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,716 | $3,311 | $2,271 | $952 |
| Change in WC | -$4,536 | $1,964 | -$5,892 | $3,529 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$35,798 | -$26,124 | -$68,008 | -$16,152 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$90,369 | -$21,568 | -$9,817 | -$194,164 |
| Inv. Sales/Matur. | $39,609 | $35,478 | $46,638 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $1,699 |
| Investing Cash Flow | -$50,760 | $13,910 | $36,821 | -$192,465 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $86,465 | $75,341 | $6,759 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$227 | $0 | $55 |
| Financing Cash Flow | $86,465 | $75,114 | $6,759 | $55 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$93 | $62,900 | -$24,428 | -$208,562 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $112,765 | $49,865 | $74,293 | $282,855 |
| End Cash | $112,672 | $112,765 | $49,865 | $74,293 |
| Free Cash Flow | -$35,798 | -$26,124 | -$68,008 | -$16,152 |